India News | New Initiative by Drug Controller General of India to Boost Ease of Doing Business
Get latest articles and stories on India at LatestLY. In a recent public notice, the Drug Controller General of India (DCGI) announced a new initiative aimed at enhancing the ease of doing business in India.
New Delhi [India], February 15 (ANI): The Drug Controller General of India (DCGI) has announced a new initiative aimed at enhancing the ease of doing business in India.
A public notice, dated February 14, outlines a plan for the DCGI to hold walk-in meetings with stakeholders.
As per the notice, the meetings, which will commence on February 20, are scheduled to take place every Tuesday and Thursday, barring gazetted holidays. These sessions will be held at the Central Drugs Standard Control Organization (CDSCO) Headquarters from 5:00 PM to 6:00 PM.
"Keeping in view the focus of Government on Ease of Doing Business in India, it has been decided that Drug Controller General of India (DCGI) will be meeting with stakeholders in walk-in meeting setup. Starting from Tuesday, 20th February, 2024, the walk-in meeting will be held on every Tuesday and Thursday (except Gazetted holidays) in CDSCO (HQ) from 5:00 PM to 6:00 PM. In the said public meeting, the problems, complaints, grievances and suggestions will be heard for suitable and swift resolution," as per the notice.
The DCGI is the head of the Central Drugs Standard Control Organisation (CDSCO). It is responsible for the approval of drugs, conduct of clinical trials, setting standards for drugs, controlling the quality of imported drugs in the country, and coordinating the activities of State Drug Control Organizations. (ANI)
(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)